Objective The objective of this study was to review the current literature and guidelines on
management of the novel coronavirus 2019 (COVID‐19 or 2019nCoV) with respect to the …

The SARS‐CoV‐2 virus, which causes coronavirus disease 2019 (COVID‐19), has rapidly
swept across the world since its identification in December 2019. Otolaryngologists are at …

More than half of COVID-19 patients are afebrile early in the disease course, yet mildly ill or
asymptomatic patients can still spread SARS-CoV-2 with high efficiency. Atypically …

Background Most outpatients with coronavirus disease 2019 (COVID-19) do not initially
demonstrate severe features requiring hospitalization. Understanding this population's …

In December 2019, a highly pathogenic and often fatal virus emerged in Wuhan, China (Q.
Li et al. 2020). By 2020, it had spread to Europe, North America, and nearly 120 countries …

Purpose To determine prevalence, severity, duration, and time from onset to diagnosis of
general and Otorhinolaryngologic symptoms related to COVID-19 in whole disease …

COVID-19 has had an impact globally with millions infected, high mortality, significant
economic ramifications, travel restrictions, national lockdowns, overloaded healthcare …

Objectives/Hypothesis The objective of this meta‐analysis was to look at the pooled
prevalence of symptoms, laboratory tests, and imaging of all COVID‐19 infected patients …

Background The impact of COVID-19 on swallowing function is not well understood. Despite
low hospital admission rates in Australia, the virus and subsequent treatment affects swallow …

The most common symptom of COVID-19 in critically ill patients is ARDS (acute respiratory
distress syndrome), with many patients requiring invasive or noninvasive respiratory support …